Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens
Abstract Objective The DNA load of Epstein-Barr virus (EBV) can be detected in different types of specimens, however, the diagnostic performance across specimens hasn’t been systematically compared in an independent study. We compared their diagnostic performances within nasopharyngeal swab (NPS), p...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14539-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849769360254566400 |
|---|---|
| author | Xue-Qi Li Dong-Feng Lin Yu-Cong Cai Shang-Hang Xie Ke-Na Lin Hang-Ning Zhou Zhi-Cong Wu Jun-Ping Ye Yi-Nan Peng Zheng Ma Ling Guo Wei Lin Su-Mei Cao |
| author_facet | Xue-Qi Li Dong-Feng Lin Yu-Cong Cai Shang-Hang Xie Ke-Na Lin Hang-Ning Zhou Zhi-Cong Wu Jun-Ping Ye Yi-Nan Peng Zheng Ma Ling Guo Wei Lin Su-Mei Cao |
| author_sort | Xue-Qi Li |
| collection | DOAJ |
| description | Abstract Objective The DNA load of Epstein-Barr virus (EBV) can be detected in different types of specimens, however, the diagnostic performance across specimens hasn’t been systematically compared in an independent study. We compared their diagnostic performances within nasopharyngeal swab (NPS), plasma, and saliva head by head in the same population in the endemic region. Methods We recruited 150 newly diagnosed NPC patients and 150 non-NPC controls from two cancer centers during the 2020–2021 years in southern China. EBV DNA loads in NPS, plasma, and saliva were tested by quantitative PCR (qPCR). Meanwhile, two EBV serology antibodies of VCA-lgA and EBNA1-lgA were assessed by enzyme-linked immunosorbent assay (ELISA). Sensitivity and specificity were compared among the EBV DNA loads across specimens, as well as with the traditional screening marker of EBV antibody score. Finally, the diagnostic performances for NPC with the combinations of the EBV DNA load and the antibody score were evaluated. Results EBV DNA loads in the NPS and plasma were higher in cases, and we further evaluated the diagnostic performances for NPC. EBV DNA load in saliva had no difference in cases and controls, P = 0.84. EBV DNA load in NPS showed a sensitivity of 92.00% (95% CI: 86.44%-95.80%) and specificity of 98.67% (95% CI: 95.27%-99.84%) for NPC. Compared with EBV DNA load in NPS, the approach in plasma exhibited a lower sensitivity of 85.33% (95% CI: 78.64%-90.57%, P < 0.01) and the same specificity of 98.67% (95% CI: 95.27%-99.84%, P = 0.66). EBV antibody score demonstrated a sensitivity of 94.67% (95% CI: 89.76%-97.67%) and a specificity of 90.00% (95% CI: 84.04%-94.29%). The combination of the EBV DNA load in NPS with EBV antibody score improved the specificity to 99.33%, while maintaining the sensitivity of 88.67%. Conclusion We demonstrated that EBV DNA load in NPS could better discriminate NPC patients from controls than the approach in plasma. EBV DNA load in saliva had no value for NPC diagnosis. The combination of EBV DNA load in NPS with EBV antibody could further improve the specificity, while maintaining a rather good sensitivity for NPC diagnosis. |
| format | Article |
| id | doaj-art-6e7ffdfd5bca46aeae08292296f4398e |
| institution | DOAJ |
| issn | 1471-2407 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj-art-6e7ffdfd5bca46aeae08292296f4398e2025-08-20T03:03:25ZengBMCBMC Cancer1471-24072025-07-012511810.1186/s12885-025-14539-5Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimensXue-Qi Li0Dong-Feng Lin1Yu-Cong Cai2Shang-Hang Xie3Ke-Na Lin4Hang-Ning Zhou5Zhi-Cong Wu6Jun-Ping Ye7Yi-Nan Peng8Zheng Ma9Ling Guo10Wei Lin11Su-Mei Cao12Department of Cancer Prevention, Sun Yat-Sen University Cancer CenterDepartment of Cancer Prevention, Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaDepartment of Cancer Prevention, Sun Yat-Sen University Cancer CenterChaoyang District Center for Disease Prevention and Control of BeijingDepartment of Cancer Prevention, Sun Yat-Sen University Cancer CenterDepartment of Cancer Prevention, Sun Yat-Sen University Cancer CenterDepartment of Cancer Prevention, Sun Yat-Sen University Cancer CenterSchool of Public Health, Guangdong Medical UniversitySchool of Public Health, Guangdong Medical UniversityState Key Laboratory of Oncology in South ChinaSchool of Public Health, Guangdong Medical UniversityDepartment of Cancer Prevention, Sun Yat-Sen University Cancer CenterAbstract Objective The DNA load of Epstein-Barr virus (EBV) can be detected in different types of specimens, however, the diagnostic performance across specimens hasn’t been systematically compared in an independent study. We compared their diagnostic performances within nasopharyngeal swab (NPS), plasma, and saliva head by head in the same population in the endemic region. Methods We recruited 150 newly diagnosed NPC patients and 150 non-NPC controls from two cancer centers during the 2020–2021 years in southern China. EBV DNA loads in NPS, plasma, and saliva were tested by quantitative PCR (qPCR). Meanwhile, two EBV serology antibodies of VCA-lgA and EBNA1-lgA were assessed by enzyme-linked immunosorbent assay (ELISA). Sensitivity and specificity were compared among the EBV DNA loads across specimens, as well as with the traditional screening marker of EBV antibody score. Finally, the diagnostic performances for NPC with the combinations of the EBV DNA load and the antibody score were evaluated. Results EBV DNA loads in the NPS and plasma were higher in cases, and we further evaluated the diagnostic performances for NPC. EBV DNA load in saliva had no difference in cases and controls, P = 0.84. EBV DNA load in NPS showed a sensitivity of 92.00% (95% CI: 86.44%-95.80%) and specificity of 98.67% (95% CI: 95.27%-99.84%) for NPC. Compared with EBV DNA load in NPS, the approach in plasma exhibited a lower sensitivity of 85.33% (95% CI: 78.64%-90.57%, P < 0.01) and the same specificity of 98.67% (95% CI: 95.27%-99.84%, P = 0.66). EBV antibody score demonstrated a sensitivity of 94.67% (95% CI: 89.76%-97.67%) and a specificity of 90.00% (95% CI: 84.04%-94.29%). The combination of the EBV DNA load in NPS with EBV antibody score improved the specificity to 99.33%, while maintaining the sensitivity of 88.67%. Conclusion We demonstrated that EBV DNA load in NPS could better discriminate NPC patients from controls than the approach in plasma. EBV DNA load in saliva had no value for NPC diagnosis. The combination of EBV DNA load in NPS with EBV antibody could further improve the specificity, while maintaining a rather good sensitivity for NPC diagnosis.https://doi.org/10.1186/s12885-025-14539-5Nasopharyngeal carcinomaEpstein-Barr virusDiagnosisCase–control studyDNA loadAntibody |
| spellingShingle | Xue-Qi Li Dong-Feng Lin Yu-Cong Cai Shang-Hang Xie Ke-Na Lin Hang-Ning Zhou Zhi-Cong Wu Jun-Ping Ye Yi-Nan Peng Zheng Ma Ling Guo Wei Lin Su-Mei Cao Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens BMC Cancer Nasopharyngeal carcinoma Epstein-Barr virus Diagnosis Case–control study DNA load Antibody |
| title | Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens |
| title_full | Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens |
| title_fullStr | Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens |
| title_full_unstemmed | Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens |
| title_short | Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens |
| title_sort | diagnostic performance of ebv dna load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens |
| topic | Nasopharyngeal carcinoma Epstein-Barr virus Diagnosis Case–control study DNA load Antibody |
| url | https://doi.org/10.1186/s12885-025-14539-5 |
| work_keys_str_mv | AT xueqili diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT dongfenglin diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT yucongcai diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT shanghangxie diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT kenalin diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT hangningzhou diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT zhicongwu diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT junpingye diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT yinanpeng diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT zhengma diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT lingguo diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT weilin diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens AT sumeicao diagnosticperformanceofebvdnaloadtestingfornasopharyngealcarcinomainnasopharyngealswaboutperformstheapproachinotherspecimens |